News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Kristin E. Rojas

Articles by Kristin E. Rojas

53 Comparison of Surgical Complications With Direct-to-Implant vs Tissue Expander Reconstruction After Wise Pattern Skin-Sparing Mastectomy

ByAreej Alhumaid,Alexandra Lopez-Aguiar,Kristin E. Rojas,Jessica Crystal,John Oeltjen,Devinder Singh,Susan B. Kesmodel

May 22nd 2025

43 Impact of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on Postoperative Complication Rates in Mastectomy With Immediate Prosthetic-Based Breast Reconstruction

ByAnshumi Desai,Emily Finklestein,Meaghan Clark,Rohan Mangal,Iago De Castro Silva,Susan B. Kesmodel,Kristin E. Rojas,Devinder Singh,Kyle Xu,Juan Catinchi-Mella

May 29th 2024

44 Variant of Uncertain Significance (VUS) Genetic Testing Results and Mastectomy Choice in Lumpectomy-Eligible Patients

ByOsvaldo Nunez,Vasanth Govind,Tizita Wolde,Rainya Heath,Talia R. Donenberg,Rachel Silva-Smith,Marie B. Jeanjean,Jessica Moore,Jessica Crystal,Susan B. Kesmodel,Kristin E. Rojas

May 28th 2024

59 Acceptability of Microbiome Sampling-Based Surgical Oncology Research in Minority Breast Cancer Patients

ByDaniel A. Gomez,Tizita Wolde,Tulay Koru-Sengul,Kristin E. Rojas

May 11th 2024

29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients

ByVijayashree Murthy,Dana Borgen,Joshua Feinberg,Kristin E. Rojas,Vijaya Natarajan,Yocasta Mejia,Michael Silver,Charusheela Andaz,Donna-Marie Manasseh

May 6th 2022

Latest Updated Articles

Trending on CancerNetwork

FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer

Combining a PCNA Inhibitor with KRAS-Targeting Agents in PDAC

Elranatamab Significantly Improves PFS in R/R Multiple Myeloma Trial

Targeting KRAS in Pancreatic Cancer: What is Daraxonrasib’s Mechanism of Action?

FDA Grants Priority Review to Tislelizumab/Zanidatamab in 1L HER2+ Gastric Cancers